Hydroxyethyl starch (HES) versus other fluid therapies: Effects on kidney function

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Dart, Allison B ^a   Mutter, Thomas C ^a   Ruth, Chelsea A ^a   Taback, Shayne P ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; DEXTRAN; FRESH FROZEN PLASMA; GELATIN; HETASTARCH;

BURN; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; EXTRACORPOREAL CIRCULATION; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; HYPOVOLEMIA; INJURY; KIDNEY FUNCTION; KIDNEY INJURY; MOLECULAR WEIGHT; ORGAN DONOR; REVIEW; SEPSIS; VASCULAR SURGERY;

EID: 70249124914     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007594     Document Type: Review

References (35)

1. American Thoracic Society. Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. American Journal of Respiratory & Critical Care Medicine 2004;170(11):1247-1259 [MEDLINE: 15563641]
2. Bagshaw SM, Bellomo R. The influence of volume management on outcome. Current Opinion in Critical Care 2007;13(5):541-548 [MEDLINE: 17762233]
3. Barron ME, Mahlon MW, Navickis RJ. A systematic review of the comparative safety of colloids. Archives of Surgery 2004;139(5):552-563 [MEDLINE: 15136357]
4. Bellomo R, Ronco C, Kellum JA,Mehta RL, Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the AcuteDialysis Quality Initiative (ADQI)Group. CriticalCare 2004;8(4):R204-12. [MEDLINE: 15312219]
5. Boldt J, Priebe HJ. Intravascular volume replacement therapy with synthetic colloids: Is there an influence on renal function?. Anesthesia & Analgesia 2003;96(2):376-382 [MEDLINE: 12538180] (Pubitemid 36125749)
6. Boldt J. Fluid choice for resuscitation of the trauma patient: a review of the physiological, pharmacological, and clinical evidence. Canadian Journal of Anaesthesia 2004;51(5):500-513 [MEDLINE: 15128639] (Pubitemid 38594375)
7. Boldt J, Schollhorn T, Munchbach J, Pabsdorf M. A total balanced volume replacement strategy using a newbalanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery. European Journal of Anaesthesiology 2007;24(3):267-275 [MEDLINE: 17054812] (Pubitemid 46245713)
8. Bork K. Pruritus precipitated by hydroxyethyl starch: a review. British Journal of Dermatology 2005;152(1):3-12. [MEDLINE: 15656795] (Pubitemid 40193827)
9. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD001319.pub2]
10. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996;348(9042):1620-1622 [MEDLINE: 8961992] (Pubitemid 27007061)
11. Cotton BA, Guy JS, Morris JA Jr, Abumrad NN. The cellular, metabolic and systemic consequences of aggressive fluid resuscitation strategies. Shock 2006;26(2):115-121 [MEDLINE: 16878017]
12. Cruz DN, Bolgan I, Perazella MA, Bonello M, de CalM, Corradi V, et al. North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE Criteria. Clinical Journal of The American Society of Nephrology: CJASN 2007;2(3):418-425 [MEDLINE: 17699446]
13. Davidson IJ. Renal impact of fluid management with colloids: A comparative review. European Journal of Anaesthesiology 2006;23(9): 721-738 [MEDLINE: 16723059]
14. Ferber HP, Nitsch E, Forster H. Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers. Arzneimittel-Forschung 1985;35(3):615-622 [MEDLINE: 2581591] (Pubitemid 15129764)
15. Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesthesia & Analgesia 1999;88(5):992-998 [MEDLINE: 10320157] (Pubitemid 29211527)
16. Grocott MP,Mythen MG, Gan TJ. Perioperative fluid management and clinical outcomes in adults. Anesthesia & Analgesia 2005;100 (4):1093-1106 [MEDLINE: 5781528]
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560 [MEDLINE: 12958120]
18. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. 2008. Available from www.cochrane-handbook.org.
19. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clinical Pharmacokinetics2005;44(7):681-699 [MEDLINE: 15966753]
20. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0 (updated February 2008). The Cochrane Collaboration. Available from www.cochrane-handbook.org, 2008.
21. Legendre C, Thervet E, Page B, Percheron A,Noel LH, Kreis H.Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993;342(8865):248-249 [MEDLINE: 7686994]
22. Lukasewitz, P, Kroh, U, Löwenstein, O, Krämer, M, Lennartz, H. Quantitative investigations to the Gewebsspeicherung of central molecular Hydroxyethylstarch 200/0.5 with patients with multi-organ failure [Quantitative Untersuchungen zur Gewebsspeicherung vonmittelmolekularerHydroxyethylstarke 200/0,5 bei Patientenmit Multiorganversagen]. Journal für Anästhesie und Intensivbehandlung 1998 ;3:42-46
23. United States Cochrane Center. Master list of journals being searched. http://apps1.jhsph.edu/cochrane/masterlist.asp (accessed May 2007).
24. McIntyre LA, Hebert PC, Fergusson D, Cook DJ, Aziz A, for the Canadian Critical Care Trials Group. A survey of Canadian intensivists' resuscitation practices in early septic shock. Critical Care 2007;11(4):R74. [MEDLINE: 17623059]
25. Miletin MS, Stewart TE, Norton PG. Influences on physicians' choices of intravenous colloids. Intensive CareMedicine 2002;28(7):917-924 [MEDLINE: 12122530]
26. Moran M, Kaspner C. Acute renal failure associated with elevated plasma oncotic pressure. New England Journal ofMedicine 1987;317 (3):150-153 [MEDLINE: 2439908] (Pubitemid 17096463)
27. Perel P, Roberts IG.Colloids versus crystalloids for fluid resuscitation in critically ill patients. CochraneDatabase of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD000567.pub3] (Pubitemid 351805192)
28. Willis NS,Mitchell R,HigginsGY,Webster AC,Craig JC. Cochrane Renal Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2008, Issue 1. Art. No.: RENAL (accessed March 2008).
29. Ricci Z,Cruz D, Ronco C. The RIFLE criteria andmortality in acute kidney injury: A systematic review. Kidney International 2008;73 (5):538-546 [MEDLINE: 18160961] (Pubitemid 351264114)
30. Schortgen F, Deye N, Brochard L, for the CRYCO Study Group. Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive CareMedicine 2004;30(12):2222-2229 [MEDLINE: 15452693] (Pubitemid 40174259)
31. Sear JW. Kidney dysfunction in the postoperative period. British Journal of Anaesthesia 2005;95(1):20-32. [MEDLINE: 15531622]
32. Verceuil A, Grocott MP, Mythen MG. Physiology, pharmacology, and rationale for colloid administration for the maintenance of effective hemodynamic stability in critically ill patients. Transfusion Medicine Reviews 2005;19(2):93-109. [MEDLINE: 15852239]
33. Waikar SS, Liu K D, Chertow GM. The incidence and prognostic significance of acute kidney injury. Current Opinion in Nephrology & Hypertension 2007;16(6):227-236 [MEDLINE: 17420666]
34. Wiedermann CJ. Hydroxyethyl starch - can the safety problems be ignored?. Wiener Klinische Wochenschrift 2004;116(17-18):583-594 [MEDLINE: 15515874]
35. Wiedermann CJ. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emergency Medicine 2008;8:1. [MEDLINE: 18218122] * Indicates the major publication for the study